Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780741 · ClinicalTrials.gov registry record · Phase 3
Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old
A Phase 3 study of Nasolacrimal Duct Obstruction, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT00780741: Completed Phase 3 study of Nasolacrimal Duct Obstruction, sponsored by Jaeb Center for Health Research.
NCT00780741 is a Phase 3 study of Nasolacrimal Duct Obstruction that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 220 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00780741, a Phase 3 study of Nasolacrimal Duct Obstruction, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is: To determine the cost-effectiveness of treating NLDO using immediate office probing compared with deferred probing in a facility setting. As part of the primary objective, the study will determine the proportion of eyes experiencing spontaneous resolution among subjects randomized to the deferred probing group. The secondary objectives are: 1. To determine the success proportion for eyes undergoing immediate office probing as an initial procedure. 2. To determine the success proportion for eyes undergoing deferred facility probing as an initial procedure.
Conditions Studied
Interventions
- PROCEDURE Immediate Office Probing
- PROCEDURE Deferred Facility Probing
Study Locations (1)
Idaho
- Intermountain Eye Centers - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00780741
The ClinicalTrials.gov registry entry for NCT00780741 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nasolacrimal Duct Obstruction appearing as the primary indexed condition, and to 2 interventions - of which Immediate Office Probing is the first listed.
NCT00780741 reports 1 study location spanning 1 distinct geographic area - top geographies include Idaho.
Frequently Asked Questions
What is clinical trial NCT00780741 about?
NCT00780741 is a clinical study titled "Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old". The purpose of this study is: To determine the cost-effectiveness of treating NLDO using immediate office probing compared with deferred probing in a facility setting. As part of the primary objective, the study will determine the proportion of eyes experiencing spontaneous resolution among subject...
What is the current status of trial NCT00780741?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 220 participants. The study started on 2008-10. Estimated completion is 2012-01.
What conditions does trial NCT00780741 study?
This clinical trial studies the following conditions: Nasolacrimal Duct Obstruction.
What interventions are being tested in trial NCT00780741?
The interventions under investigation include: Immediate Office Probing (PROCEDURE), Deferred Facility Probing (PROCEDURE).
Who is sponsoring clinical trial NCT00780741?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00780741 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasolacrimal Duct Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.